Target Price | $193.80 |
Price | $179.33 |
Potential |
8.07%
register free of charge
|
Number of Estimates | 19 |
19 Analysts have issued a price target Quest Diagnostics 2026 .
The average Quest Diagnostics target price is $193.80.
This is
8.07%
register free of charge
$210.00
17.10%
register free of charge
$171.03
4.63%
register free of charge
|
|
A rating was issued by 24 analysts: 12 Analysts recommend Quest Diagnostics to buy, 12 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Quest Diagnostics stock has an average upside potential 2026 of
8.07%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 9.87 | 10.97 |
6.70% | 11.13% | |
EBITDA Margin | 15.55% | 19.97% |
1.03% | 28.43% | |
Net Margin | 8.77% | 10.05% |
4.52% | 14.57% |
21 Analysts have issued a sales forecast Quest Diagnostics 2025 . The average Quest Diagnostics sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Quest Diagnostics EBITDA forecast 2025. The average Quest Diagnostics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
21 Quest Diagnostics Analysts have issued a net profit forecast 2025. The average Quest Diagnostics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 7.66 | 9.84 |
1.86% | 28.46% | |
P/E | 18.22 | |
EV/Sales | 2.32 |
21 Analysts have issued a Quest Diagnostics forecast for earnings per share. The average Quest Diagnostics EPS is
This results in the following potential growth metrics and future valuations:
Quest Diagnostics...
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Locked
➜
Locked
|
Locked | Oct 02 2025 |
Baird |
Locked
➜
Locked
|
Locked | Aug 25 2025 |
Deutsche Bank |
Locked
➜
Locked
|
Locked | Jul 23 2025 |
UBS |
Locked
➜
Locked
|
Locked | Jul 23 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Jul 23 2025 |
UBS |
Locked
➜
Locked
|
Locked | Jul 18 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | May 06 2025 |
Analyst Rating | Date |
---|---|
Locked
Barclays:
Locked
➜
Locked
|
Oct 02 2025 |
Locked
Baird:
Locked
➜
Locked
|
Aug 25 2025 |
Locked
Deutsche Bank:
Locked
➜
Locked
|
Jul 23 2025 |
Locked
UBS:
Locked
➜
Locked
|
Jul 23 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Jul 23 2025 |
Locked
UBS:
Locked
➜
Locked
|
Jul 18 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
May 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.